NodThera

Developing small molecule inhibitors of the NLRP3 inflammasome.

F-Prime Team

Sector

Life Sciences

Category

Therapeutics

Location

Cambridge, United Kingdom

Initial Investment

2018
Developing small molecule inhibitors of the NLRP3 inflammasome.

NodThera is a biotech engaged in innate immune/inflammasome research. Our leading project is focused on developing inhibitors of the NLRP3 inflammasome for the treatment of inflammatory and neuroinflammatory diseases.